17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a...

Gynecologic Oncology 2012 Vol. 127; Iss. 3

17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma

Marta Szajnik, Miroslaw J. Szczepanski, Esther Elishaev, Carmen Visus, Diana Lenzner, Maciej Zabel, Marta Glura, Albert B. DeLeo, Theresa L. Whiteside
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
127
Year:
2012
Language:
english
DOI:
10.1016/j.ygyno.2012.08.010
File:
PDF, 1.01 MB
english, 2012
Conversion to is in progress
Conversion to is failed